Chinese Women and Mammography Screening

This study has been completed.
Sponsor:
Collaborators:
American Cancer Society, Inc.
Susan G. Komen Breast Cancer Foundation
Information provided by (Responsible Party):
Judy Wang, Georgetown University
ClinicalTrials.gov Identifier:
NCT01261520
First received: December 15, 2010
Last updated: April 23, 2012
Last verified: April 2012
  Purpose

This study examined whether a culturally-tailored video has a greater impact on increasing mammography use in Chinese American women and improving barriers to mammography screening compared to a generic, non-tailored video and a printed fact sheet (control group).


Condition Intervention Phase
Study Chinese Women Who Have Not Adhered to American Cancer Society Mammography Screening Guideline
Behavioral: Culturally-tailored video
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Screening
Official Title: Promoting Adherence to Mammography Use in Chinese Women

Resource links provided by NLM:


Further study details as provided by Georgetown University:

Primary Outcome Measures:
  • Receipt of mammography screening [ Time Frame: six month post intervention ] [ Designated as safety issue: No ]

Enrollment: 671
Study Start Date: July 2005
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Culturally-tailored video
The culturally-tailored video was designed to focus on Chinese women's cultural health beliefs and align with Chinese customs, norms, and values, which includes two segments: 1) a soap-opera and 2) recommendation from a Chinese female physician.
Behavioral: Culturally-tailored video
A 18 minute DVD made in Chinese language (i.e. Mandarin and Cantonese)

Detailed Description:

This study examined the efficacy of a culturally-tailored video in increasing mammography use among non-adherent Chinese women (vs. a generic video and control fact sheet). A total of 671 Chinese American women from metropolitan Washington, DC and New York city were enrolled to participate in this study. The majority of participants were recruited from on-site community events and some were recruited through public advertisement and referrals. Participants who completed baseline assessment were randomized to one of the three groups: 1) viewing an 18-minute cultural video, 2) viewing an 18-minute generic video, and 3) reading a fact sheet (control group). Participants were interviewed twice after intervention:1) process evaluation 2-4 weeks post intervention regarding participants' feedback on the materials and repeated key measures of knowledge, cultural views, and health beliefs and 2) outcome evaluation six-months post intervention that assesses actual receipt of mammography use.

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chinese American women had not had a mammography in the past 12 months
  • Chinese American women had no personal history of breast cancer
  • Chinese American women had no mammogram scheduled when enrolled

Exclusion Criteria:

  • Non-Chinese Women
  • Regular mammography users
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01261520

Locations
United States, District of Columbia
Cancer Control Program, Georgetown University
Washington, District of Columbia, United States, 20007
Sponsors and Collaborators
Georgetown University
American Cancer Society, Inc.
Susan G. Komen Breast Cancer Foundation
Investigators
Principal Investigator: Judy H Wang, Ph.D. Georgetown University
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Judy Wang, Assistant Professor, Georgetown University
ClinicalTrials.gov Identifier: NCT01261520     History of Changes
Other Study ID Numbers: GU 2005-167, MRSGT-05-104-01-CPPB, R03CA117552
Study First Received: December 15, 2010
Last Updated: April 23, 2012
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on September 18, 2014